Profile data is unavailable for this security.
About the company
Bluestar Adisseo Co is a China-based company mainly engaged in the research, development, production and sale of animal nutrition additives. The Company operates its businesses through one segment: the Nutrition and Health segment. The Company's products are divided into two categories: functional products and specialty products. The Company's functional products mainly include methionine and vitamins. The Company's specialty products mainly include organic selenium, enzyme preparations, feed emulsifiers, rumen-encapsulated amino acids, innovative ruminant solutions, as well as probiotic products and other health solutions. The Company mainly operates its businesses in the domestic and overseas markets.
- Revenue in CNY (TTM)17.09bn
- Net income in CNY1.19bn
- Incorporated1999
- Employees2.93k
- LocationBluestar Adisseo CoNo. 9Beitucheng West Road, Chaoyang DistrictBEIJING 100029ChinaCHN
- Phone+86 1 061958802
- Fax+86 1 061958805
- Websitehttps://www.adisseo.com.cn
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hubei Jumpcan Pharmaceutical Co Ltd | 6.14bn | 1.65bn | 25.04bn | 5.03k | 15.11 | 1.81 | -- | 4.08 | 1.80 | 1.80 | 6.69 | 15.02 | 0.3543 | 2.99 | 3.59 | 1,222,407.00 | 9.53 | 15.19 | 11.67 | 19.57 | 75.44 | 81.73 | 26.91 | 26.02 | 5.18 | -- | 0.0437 | 46.90 | -16.96 | 2.93 | -10.32 | 9.30 | -20.43 | 11.19 |
| Kangmei Pharmaceutical Co Ltd | 5.28bn | 16.64m | 26.14bn | 4.23k | 1,643.48 | 3.64 | -- | 4.95 | 0.0012 | 0.0012 | 0.3973 | 0.5197 | 0.3785 | 1.64 | 2.23 | 1,246,204.00 | 0.1368 | -21.82 | 0.2232 | -42.17 | 17.12 | -92.73 | 0.3614 | -108.18 | 0.7875 | -- | 0.0162 | -- | 6.47 | -14.63 | -91.64 | -- | -33.46 | -- |
| Tianjin Pharmcetl Da Ren Tang Grp Cp Ltd | 5.37bn | 3.58bn | 29.37bn | 3.84k | 9.29 | 3.69 | -- | 5.47 | 4.65 | 4.65 | 6.98 | 11.70 | 0.4758 | 1.35 | 3.16 | 1,399,130.00 | 31.64 | 11.74 | 45.06 | 16.76 | 64.27 | 42.04 | 66.50 | 14.81 | 2.33 | -- | 0.0056 | 54.04 | -11.14 | 0.8791 | 125.94 | 28.94 | -10.54 | 33.67 |
| Xiamen Amoytop Biotech Co Ltd | 3.34bn | 939.58m | 29.55bn | 2.42k | 31.34 | 9.79 | -- | 8.84 | 2.31 | 2.31 | 8.22 | 7.40 | 1.03 | 0.8127 | 4.99 | 1,379,284.00 | 29.05 | 22.72 | 33.93 | 26.54 | 92.37 | 91.62 | 28.11 | 23.51 | 3.20 | -- | 0.0448 | 28.80 | 34.13 | 31.02 | 49.00 | 66.70 | 41.17 | 90.06 |
| Bluestar Adisseo Co | 17.09bn | 1.19bn | 31.11bn | 2.93k | 22.71 | 1.60 | -- | 1.82 | 0.4447 | 0.4447 | 6.37 | 6.31 | 0.7204 | 5.30 | 8.18 | 5,834,541.00 | 5.03 | 5.20 | 6.05 | 6.63 | 27.69 | 29.69 | 6.99 | 8.12 | 1.12 | 10.31 | 0.1377 | 30.01 | 17.83 | 6.88 | 2,208.66 | 3.95 | 5.53 | -7.02 |
| Shanghai Junshi Biosciences Co Ltd | 2.48bn | -949.86m | 31.19bn | 2.67k | -- | 5.66 | -- | 12.56 | -0.96 | -0.96 | 2.51 | 6.05 | 0.2203 | 0.8436 | 5.48 | 963,148.80 | -9.45 | -17.61 | -12.31 | -22.00 | 81.59 | 68.46 | -42.92 | -84.56 | 1.43 | -23.04 | 0.3629 | -- | 29.67 | 20.24 | 43.90 | -- | -4.33 | -- |
| Humanwell Healthcare Group Co Ltd | 24.18bn | 1.43bn | 31.34bn | 17.65k | 21.97 | 1.66 | -- | 1.30 | 0.8741 | 0.8741 | 14.84 | 11.59 | 0.6519 | 3.63 | 2.48 | 1,369,715.00 | 5.00 | 6.40 | 8.73 | 12.55 | 44.53 | 43.83 | 7.67 | 9.90 | 1.40 | 362.14 | 0.2889 | 25.97 | 3.71 | 3.13 | -37.70 | 11.15 | 4.75 | 56.54 |
| Beijing Tiantan Biological Products Corp | 6.42bn | 1.32bn | 32.23bn | 5.30k | 24.49 | 2.81 | -- | 5.02 | 0.6656 | 0.6656 | 3.25 | 5.80 | 0.4002 | 0.9382 | 11.21 | 1,212,453.00 | 11.25 | 11.93 | 16.06 | 16.79 | 45.65 | 50.69 | 28.10 | 29.69 | 3.08 | -- | 0.0152 | 16.24 | 16.44 | 12.94 | 39.58 | 20.45 | 15.19 | 23.56 |
| Sunshine Guojian Pharmcutcl Shngh Co Ltd | 1.37bn | 870.39m | 36.34bn | 995.00 | 41.95 | 6.15 | -- | 26.53 | 1.40 | 1.40 | 2.21 | 9.56 | 0.186 | 1.54 | 4.55 | 1,377,045.00 | 11.66 | 3.14 | 15.35 | 3.34 | 74.88 | 77.37 | 62.65 | 16.95 | 1.97 | -- | 0.00 | 12.57 | 17.70 | 0.2733 | 139.15 | 25.17 | 16.61 | -- |
Data as of Feb 13 2026. Currency figures normalised to Bluestar Adisseo Co's reporting currency: Chinese Yuan Renminbi CNY
1.69%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Fullgoal Fund Management Co., Ltd.as of 30 Jun 2025 | 7.71m | 0.29% |
| China Asset Management Co., Ltd.as of 30 Jun 2025 | 6.90m | 0.26% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2025 | 6.40m | 0.24% |
| Guotai Asset Management Co., Ltd.as of 30 Jun 2025 | 6.34m | 0.24% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2025 | 4.70m | 0.18% |
| The Vanguard Group, Inc.as of 04 Feb 2026 | 3.37m | 0.13% |
| Tian Hong Asset Management Co., Ltd.as of 30 Jun 2025 | 3.25m | 0.12% |
| CCB Principal Asset Management Co., Ltd.as of 30 Jun 2025 | 2.33m | 0.09% |
| China Merchants Fund Management Co., Ltd.as of 30 Jun 2025 | 2.24m | 0.08% |
| Shanghai Guotai Junan Securities Assets Management Co., Ltd.as of 30 Jun 2025 | 2.10m | 0.08% |
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
